Published in J Immunol on March 01, 1975
The presence of two Fc receptors on mouse macrophages: evidence from a variant cell line and differential trypsin sensitivity. J Exp Med (1977) 3.55
Functional properties of bovine IgG1 and IgG2: interaction with complement, macrophages, neutrophils and skin. Immunology (1979) 2.08
Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay. J Clin Invest (1981) 1.57
Alveolar macrophages. II. Inhibition of lymphocyte proliferation by purified macrophages from rat lung. Immunology (1979) 1.40
The pig synovium, II. Some properties of isolated intimal cells. J Anat (1977) 1.35
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun (1977) 1.34
Alveolar macrophages. III. Studies on the mechanisms of inhibition of T-cell proliferation. Immunology (1979) 1.29
Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotides. J Exp Med (1980) 1.16
Macrophage activation: increased ingestion of IgG-coated erythrocytes after administration of interferon inducers to mice. J Exp Med (1978) 1.12
Fc-receptor-bearing macrophages isolated from hypersensitivity and foreign-body granulomas. Delineation of macrophage dynamics, fc receptor density/avidity and specificity. Am J Pathol (1979) 1.12
Cellular requirements for the formation of EA rosettes by human monocytes. Immunology (1978) 1.08
Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA). Clin Exp Immunol (1980) 1.04
Retinoids as regulators of macrophage function. Immunology (1980) 1.03
Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection. J Virol (1987) 0.99
Macrophage functional heterogeneity in vivo. Macrolocal and microlocal macrophage activation, identified by double-staining tissue sections of BCG granulomas for pairs of enzymes. Am J Pathol (1980) 0.95
Etiology of the liver granulomatous response in Schistosoma mansoni-infected athymic nude mice. Infect Immun (1980) 0.92
Interferon-induced changes in the monocyte membrane: inhibition by retinol and retinoic acid. Immunology (1982) 0.89
Kinetics of phagocytosis of Staphylococcus aureus by alveolar and peritoneal macrophages. Infect Immun (1979) 0.85
Alveolar macrophage subpopulations' responsiveness to chemotactic stimuli. Am J Pathol (1988) 0.83
Activation of alveolar macrophages following infection with the parasitic nematode Nippostrongylus brasiliensis. Immunology (1985) 0.83
Altered expression of human monocyte Fc receptors in Plasmodium falciparum malaria. Infect Immun (1984) 0.83
Activated macrophages pre-incubated in vitro enhance rather than suppress mitogen-stimulated lymphocyte transformation. Immunology (1980) 0.82
Granzyme B expression is enhanced in human monocytes by TLR8 agonists and contributes to antibody-dependent cellular cytotoxicity. J Immunol (2015) 0.82
Murine macrophage-lymphocyte interactions: scanning electron microscopic study. Infect Immun (1978) 0.81
Role of antibodies and host cells in plaque enhancement of Murray Valley encephalitis virus. J Virol (1983) 0.80
Influence of various macrophage populations on Con-A induced T-cell proliferation. Immunology (1980) 0.80
Attachment and ingestion of mycoplasmas by mouse macrophages. I. Kinetics of the interaction and effects on phagocyte glucose metabolism. Am J Pathol (1977) 0.80
Shedding and synthesis de novo of Fc and C3b receptors by cultured guinea-pig macrophages. Clin Exp Immunol (1988) 0.79
The carbohydrates associated with the surfaces of hamster alveolar macrophages: a study using fluorescein-conjugated lectins. J Anat (1985) 0.78
Effects of cholera exotoxin on Fc receptor activity of lymphoid cells and mononuclear phagocytes. Immunology (1977) 0.78
Functional heterogeneity of isopycnic fractions of rat alveolar macrophages. Infect Immun (1984) 0.78
Relationships between different functional properties of human monocytes. Immunology (1977) 0.77
Heterogeneity of rat peritoneal and alveolar macrophage populations: characterization of their surface antigens by antisera. Br J Exp Pathol (1981) 0.75
Alveolar macrophage-lymphocyte rosette formation: failure of levamisole to alter activity. Infect Immun (1977) 0.75
Surface receptors on lymphoreticular cells: sensory devices for host recognition of foreign antigens and neoplasia. Can Med Assoc J (1980) 0.75
Effects of polynucleotides and levamisole on alveolar macrophage morphology and receptor activity. Infect Immun (1977) 0.75
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80
Altered bowel habit and menstruation. Lancet (1976) 1.73
Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71
Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69
Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67
Mortality in Crohn's disease. Q J Med (1980) 1.62
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57
pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57
[Not Available]. BioDrugs (1997) 1.56
Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Complications of carbenoxolone therapy. Br Med J (1974) 1.54
The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51
Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46
Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41
Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41
Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40
Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40
Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40
Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40
Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Etiology of gastric ulcer. Gastroenterology (1972) 1.37
Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36
Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36
'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33
Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29
Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29
Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods. Pediatr Cardiol (2000) 1.28
Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis. J Pharm Pharmacol (1983) 1.22
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Br Med J (Clin Res Ed) (1983) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br J Clin Pharmacol (1984) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Coarse mucosal folds in the duodenum. Q J Med (1968) 1.18
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur J Immunol (1986) 1.17
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci (1981) 1.13
Effect of ulcerative colitis and smoking on rectal blood flow. Gut (1990) 1.13
Fungal endophthalmitis following intraocular lens implantation. Am J Ophthalmol (1977) 1.12
A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer. Gut (1970) 1.12
Immunoglobulin E in rectal mucosa of patients with proctitis. Lancet (1975) 1.11
Diurnal variation in the quantitative EEG in healthy adult volunteers. Br J Clin Pharmacol (2000) 1.11
Increased reflux of bile into the stomach in gastric ulcer. Gut (1968) 1.10
Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694. Br J Clin Pharmacol (1981) 1.10
Receptor for monomeric IgM on guinea-pig splenic macrophages. Nature (1973) 1.10
Angina-like esophageal pain: differentiation from cardiac pain by history. J Clin Gastroenterol (1985) 1.07
A homeodomain protein selectively expressed in noradrenergic tissue regulates transcription of neurotransmitter biosynthetic genes. J Neurosci (1995) 1.07
Effect of information booklet on patients' anxiety levels and consultation rates in Crohn's disease. Public Health (1986) 1.05
Bile reflux in gastro-oesophageal disease. Clin Gastroenterol (1977) 1.05
Localization of a novel septin protein, hCDCrel-1, in neurons of human brain. Neuroreport (1998) 1.03
Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides. Nature (1975) 1.03
Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut (1988) 1.03
Gastric acidity and iron absorption. Br J Haematol (1966) 1.03
Retinoids as regulators of macrophage function. Immunology (1980) 1.03
Nicotine enemas for active ulcerative colitis--a pilot study. Aliment Pharmacol Ther (1997) 1.01
Gastric emptying after intestinal resection in Crohn's disease. Br J Surg (1983) 1.00
Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J (1980) 1.00
Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med (1995) 1.00
Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis (1988) 0.99
Azathioprine in Crohn's disease. Lancet (1970) 0.99
Tumor surveillance: how tumors may resist macrophage-mediated host defense. Science (1979) 0.99
Effect of deglycyrrhizinated liquorice on gastric mucosal damage by aspirin. Scand J Gastroenterol (1979) 0.98
Female gender is a major determinant of changing subsite distribution of colorectal cancer with age. Cancer (1985) 0.98
Male fertility in Crohn's disease. Postgrad Med J (1986) 0.98
Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue. Surgery (1992) 0.98
Altered subcellular distribution of transcriptional regulators in response to Abeta peptide and during Alzheimer's disease. Mech Ageing Dev (2001) 0.97
Inflammatory bowel disease and smoking--a review. Am J Gastroenterol (1998) 0.97
Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol (1999) 0.97
Stress management for irritable bowel syndrome: a controlled trial. Digestion (1991) 0.96
Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology (2001) 0.96